RESUMO
Objective: To synthesize the evidence on the effectiveness of hospital transition care in the elderly to support decision-making. Method: This rapid systematic review followed the recommendations of the Cochrane Rapid Reviews Methods Group. Studies were selected from the PubMed, EMBASE, Cochrane Library, and Virtual Health Library (BVS) databases using the following criteria: focus on the elderly as population; provision of hospital transition care as intervention; care as usual (non-transition care) as comparator; and effectiveness of the presence vs. absence of transition care as the outcome, with effectiveness defined as improvement in any evaluated parameter. Systematic reviews published in Portuguese, English, or Spanish, with or without meta-analysis, that assessed hospital transition care in elderly individuals were included. Studies lacking a description of the intervention and target population were excluded. Results: Of the 207 identified reviews, 18 were included. The studies were conducted in 21 countries, with 10 studies conducted in Europe and one in Brazil. The effectiveness of care for the elderly was demonstrated through increased adherence to medication regimens, reduced adverse events and medication-related errors, improved functional status, reduced falls, and reduced healthcare costs. Conclusions: Despite the evidence indicating the effectiveness of hospital transition care, further research is needed to develop more robust indicators of clinical improvement and integration into healthcare systems.
Objetivo: Sintetizar la evidencia sobre la eficacia de la atención transitoria prestada a las personas mayores después del alta hospitalaria con el fin de ayudar a los gerentes en la toma de decisiones. Métodos: En esta revisión sistemática rápida se siguieron las recomendaciones del Grupo Cochrane de Métodos de Revisiones Rápidas y se seleccionaron estudios en las bases de datos PubMed, EMBASE, Biblioteca Cochrane y Biblioteca Virtual de Salud. Para la selección de los estudios se consideraron los siguientes criterios: como población, personas mayores; como intervención, la prestación de atención transitoria después del alta hospitalaria; como comparador, la ausencia de atención transitoria después del alta hospitalaria; y como resultado, la eficacia del uso frente a la falta de uso de la atención transitoria, tomando como definición de eficacia la mejora de cualquier parámetro evaluado. Se incluyeron revisiones sistemáticas publicadas en español, inglés o portugués, con o sin metanálisis, en las cuales se evaluara la atención transitoria prestada a personas mayores después del alta hospitalaria y se excluyeron los estudios sin descripción de la intervención o del público destinatario correspondientes. Resultados: Se incluyeron 18 de las 207 revisiones halladas. Los estudios se habían realizado en 21 países (10 estudios en Europa y uno en Brasil). Se demostró la eficacia de la atención prestada a las personas mayores en cuanto a una mayor observancia de los tratamientos farmacológicos, una reducción del número de eventos adversos y errores en el uso de los medicamentos, una mejora del estado funcional de las personas mayores, una disminución de las caídas y un menor costo de la atención. Conclusiones: A pesar de haberse comprobado la eficacia de la atención transitoria, se necesitan nuevas investigaciones para elaborar indicadores más sólidos de la mejora clínica y de la integración en los sistemas de salud.
RESUMO
[RESUMO]. Objetivo. Sintetizar as evidências de efetividade dos cuidados de transição em idosos após alta hospitalar para subsidiar gestores para a tomada de decisão. Métodos. Esta revisão sistemática rápida seguiu as recomendações do Cochrane Rapid Reviews Methods Group e selecionou estudos nas bases de dados Pubmed, EMBASE, Cochrane Library e Biblioteca Virtual em Saúde. Para selecionar os estudos, foram considerados: como população, indivíduos idosos; como intervenção, a realização de cuidados de transição após alta hospitalar; como comparador, a ausência de cuidado de transição após alta hospitalar; e como desfecho, a efetividade da presença vs. ausência de cuidados de transição, sendo efetividade definida como a melhora em qualquer parâmetro avaliado. Foram incluídas revisões sistemáticas publicadas em português, inglês ou espanhol, com ou sem metanálise, que avaliaram os cuidados de transição para idosos após alta hospitalar; e excluídos estudos sem descrição da intervenção e do público-alvo. Resultados. Das 207 revisões identificadas, 18 foram incluídas. Os estudos foram realizados em 21 países, sendo 10 estudos desenvolvidos na Europa e um no Brasil. A efetividade dos cuidados com os idosos foi demonstrada por maior adesão aos tratamentos medicamentosos, redução dos eventos adversos e dos erros relacionados aos medicamentos, melhora do estado funcional nos idosos, redução de quedas e redução dos custos no cuidado. Conclusões. Apesar das evidências que indicam a efetividade dos cuidados de transição, novas pesquisas são necessárias para desenvolver indicadores mais robustos de melhora clínica e integração aos sistemas de saúde.
[ABSTRACT]. Objective. To synthesize the evidence on the effectiveness of hospital transition care in the elderly to support decision-making. Method. This rapid systematic review followed the recommendations of the Cochrane Rapid Reviews Methods Group. Studies were selected from the PubMed, EMBASE, Cochrane Library, and Virtual Health Library (BVS) databases using the following criteria: focus on the elderly as population; provision of hospital transition care as intervention; care as usual (non-transition care) as comparator; and effectiveness of the presence vs. absence of transition care as the outcome, with effectiveness defined as improvement in any evaluated parameter. Systematic reviews published in Portuguese, English, or Spanish, with or without meta-analysis, that assessed hospital transition care in elderly individuals were included. Studies lacking a description of the intervention and target population were excluded. Results. Of the 207 identified reviews, 18 were included. The studies were conducted in 21 countries, with 10 studies conducted in Europe and one in Brazil. The effectiveness of care for the elderly was demonstrated through increased adherence to medication regimens, reduced adverse events and medication-related errors, improved functional status, reduced falls, and reduced healthcare costs. Conclusions. Despite the evidence indicating the effectiveness of hospital transition care, further research is needed to develop more robust indicators of clinical improvement and integration into healthcare systems.
[RESUMEN]. Objetivo. Sintetizar la evidencia sobre la eficacia de la atención transitoria prestada a las personas mayores después del alta hospitalaria con el fin de ayudar a los gerentes en la toma de decisiones. Métodos. En esta revisión sistemática rápida se siguieron las recomendaciones del Grupo Cochrane de Métodos de Revisiones Rápidas y se seleccionaron estudios en las bases de datos PubMed, EMBASE, Biblioteca Cochrane y Biblioteca Virtual de Salud. Para la selección de los estudios se consideraron los siguientes criterios: como población, personas mayores; como intervención, la prestación de atención transitoria después del alta hospitalaria; como comparador, la ausencia de atención transitoria después del alta hospitalaria; y como resultado, la eficacia del uso frente a la falta de uso de la atención transitoria, tomando como definición de eficacia la mejora de cualquier parámetro evaluado. Se incluyeron revisiones sistemáticas publicadas en español, inglés o portugués, con o sin metanálisis, en las cuales se evaluara la atención transitoria prestada a personas mayores después del alta hospitalaria y se excluyeron los estudios sin descripción de la interven- ción o del público destinatario correspondientes. Resultados. Se incluyeron 18 de las 207 revisiones halladas. Los estudios se habían realizado en 21 países (10 estudios en Europa y uno en Brasil). Se demostró la eficacia de la atención prestada a las personas mayo- res en cuanto a una mayor observancia de los tratamientos farmacológicos, una reducción del número de eventos adversos y errores en el uso de los medicamentos, una mejora del estado funcional de las personas mayores, una disminución de las caídas y un menor costo de la atención. Conclusiones. A pesar de haberse comprobado la eficacia de la atención transitoria, se necesitan nuevas investigaciones para elaborar indicadores más sólidos de la mejora clínica y de la integración en los sistemas de salud.
Assuntos
Cuidado Transicional , Serviços de Saúde para Idosos , Política de Saúde , Efetividade , Cuidado Transicional , Serviços de Saúde para Idosos , Política de Saúde , Efetividade , Cuidado Transicional , Serviços de Saúde para Idosos , Política de Saúde , EfetividadeRESUMO
INTRODUCTION: Atypical antipsychotics have been studied to treat autism spectrum disorder (ASD). However, like little is known about whether these drugs are effective and safe when compared in controlled and non-controlled settings. This study aims to assess the efficacy and safety of second-generation antipsychotics in ASD in randomised controlled trials (RCT) and observational studies. METHODS AND ANALYSIS: This systematic review will include RCT and prospective cohorts evaluating second-generation antipsychotics in people 5 years and older diagnosed with ASD. Searches will be conducted in Medline, Embase, Cochrane Library, Epistemonikos, Lilacs, CINAHL, PsycINFO, trial registries and grey literature databases without restriction on publication status, year of publication and language. The primary outcomes will be symptoms of aggressive behaviour, quality of life for the individual or their careers, and discontinuation or dropouts/withdrawals of antipsychotics due to adverse events. The secondary outcomes are other not serious adverse events and adherence to pharmacotherapy. Selection, data extraction, and quality assessment will be performed by pairs of reviewers, independently. The Risk of Bias 2 (RoB 2) and Risk of Bias in Non-Randomised Studies of Interventions (ROBINS-I) tools will be used to assess the risk of bias in the included studies. If appropriate, a meta-analysis and network meta-analysis will be conducted to synthesise the results. The overall quality of the evidence for each outcome will be determined by the Recommendation, Assessment, Development and Evaluation approach. ETHICS AND DISSEMINATION: This study will systematically summarise the existing evidence evaluating the use of second-generation antipsychotics for treating ASD, in controlled and uncontrolled studies. The results of this review will be disseminated through peer-reviewed publications and conference presentations. PROSPERO REGISTRATION NUMBER: CRD42022353795.
Assuntos
Antipsicóticos , Transtorno do Espectro Autista , Humanos , Antipsicóticos/efeitos adversos , Transtorno do Espectro Autista/tratamento farmacológico , Viés , Metanálise como Assunto , Estudos Observacionais como Assunto , Ensaios Clínicos Controlados Aleatórios como Assunto , Projetos de Pesquisa , Revisões Sistemáticas como AssuntoRESUMO
RESUMO Objetivo. Sintetizar as evidências de efetividade dos cuidados de transição em idosos após alta hospitalar para subsidiar gestores para a tomada de decisão. Métodos. Esta revisão sistemática rápida seguiu as recomendações do Cochrane Rapid Reviews Methods Group e selecionou estudos nas bases de dados Pubmed, EMBASE, Cochrane Library e Biblioteca Virtual em Saúde. Para selecionar os estudos, foram considerados: como população, indivíduos idosos; como intervenção, a realização de cuidados de transição após alta hospitalar; como comparador, a ausência de cuidado de transição após alta hospitalar; e como desfecho, a efetividade da presença vs. ausência de cuidados de transição, sendo efetividade definida como a melhora em qualquer parâmetro avaliado. Foram incluídas revisões sistemáticas publicadas em português, inglês ou espanhol, com ou sem metanálise, que avaliaram os cuidados de transição para idosos após alta hospitalar; e excluídos estudos sem descrição da intervenção e do público-alvo. Resultados. Das 207 revisões identificadas, 18 foram incluídas. Os estudos foram realizados em 21 países, sendo 10 estudos desenvolvidos na Europa e um no Brasil. A efetividade dos cuidados com os idosos foi demonstrada por maior adesão aos tratamentos medicamentosos, redução dos eventos adversos e dos erros relacionados aos medicamentos, melhora do estado funcional nos idosos, redução de quedas e redução dos custos no cuidado. Conclusões. Apesar das evidências que indicam a efetividade dos cuidados de transição, novas pesquisas são necessárias para desenvolver indicadores mais robustos de melhora clínica e integração aos sistemas de saúde.
ABSTRACT Objective. To synthesize the evidence on the effectiveness of hospital transition care in the elderly to support decision-making. Method. This rapid systematic review followed the recommendations of the Cochrane Rapid Reviews Methods Group. Studies were selected from the PubMed, EMBASE, Cochrane Library, and Virtual Health Library (BVS) databases using the following criteria: focus on the elderly as population; provision of hospital transition care as intervention; care as usual (non-transition care) as comparator; and effectiveness of the presence vs. absence of transition care as the outcome, with effectiveness defined as improvement in any evaluated parameter. Systematic reviews published in Portuguese, English, or Spanish, with or without meta-analysis, that assessed hospital transition care in elderly individuals were included. Studies lacking a description of the intervention and target population were excluded. Results. Of the 207 identified reviews, 18 were included. The studies were conducted in 21 countries, with 10 studies conducted in Europe and one in Brazil. The effectiveness of care for the elderly was demonstrated through increased adherence to medication regimens, reduced adverse events and medication-related errors, improved functional status, reduced falls, and reduced healthcare costs. Conclusions. Despite the evidence indicating the effectiveness of hospital transition care, further research is needed to develop more robust indicators of clinical improvement and integration into healthcare systems.
RESUMEN Objetivo. Sintetizar la evidencia sobre la eficacia de la atención transitoria prestada a las personas mayores después del alta hospitalaria con el fin de ayudar a los gerentes en la toma de decisiones. Métodos. En esta revisión sistemática rápida se siguieron las recomendaciones del Grupo Cochrane de Métodos de Revisiones Rápidas y se seleccionaron estudios en las bases de datos PubMed, EMBASE, Biblioteca Cochrane y Biblioteca Virtual de Salud. Para la selección de los estudios se consideraron los siguientes criterios: como población, personas mayores; como intervención, la prestación de atención transitoria después del alta hospitalaria; como comparador, la ausencia de atención transitoria después del alta hospitalaria; y como resultado, la eficacia del uso frente a la falta de uso de la atención transitoria, tomando como definición de eficacia la mejora de cualquier parámetro evaluado. Se incluyeron revisiones sistemáticas publicadas en español, inglés o portugués, con o sin metanálisis, en las cuales se evaluara la atención transitoria prestada a personas mayores después del alta hospitalaria y se excluyeron los estudios sin descripción de la intervención o del público destinatario correspondientes. Resultados. Se incluyeron 18 de las 207 revisiones halladas. Los estudios se habían realizado en 21 países (10 estudios en Europa y uno en Brasil). Se demostró la eficacia de la atención prestada a las personas mayores en cuanto a una mayor observancia de los tratamientos farmacológicos, una reducción del número de eventos adversos y errores en el uso de los medicamentos, una mejora del estado funcional de las personas mayores, una disminución de las caídas y un menor costo de la atención. Conclusiones. A pesar de haberse comprobado la eficacia de la atención transitoria, se necesitan nuevas investigaciones para elaborar indicadores más sólidos de la mejora clínica y de la integración en los sistemas de salud.
RESUMO
BACKGROUND: The management of type 2 diabetes mellitus (T2DM) requires a complex and organized care that includes patient's lifestyle change. Additionally, emotional well-being is an important part of self-management, and it may impair the individual's adherence. Therefore, equipping the patients with the necessary coping and self-care techniques may be an important step in managing diabetes. OBJECTIVE: To evaluate the effect of interventions using established mindfulness-based protocols on glycemic control of individuals with T2DM. METHODS: Data sources: Two electronic databases (PubMed and EMBASE) were searched from inception to December 2019. We limited our search to published studies in English, Spanish and Portuguese languages. STUDY SELECTION: Randomized clinical trials that assessed the effects of mindfulness in individuals with T2DM were selected. DATA EXTRACTION: Two authors independently assessed the risk of bias and extracted data from the included trials. Data were pooled using inverse-variance random-effects meta-analyses. The quality of evidence was assessed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system. RESULTS: Four randomized trials were included. There were no differences in blood glucose change (mean difference between groups (MD) -0.73mg/dl; 95% CI, -10.49; 9.02; I2 =0%; very low quality of evidence) or glycated hemoglobin (MD 0.05%; 95%CI -0.22 to 0.32; I2 =29%; very low quality of evidence). CONCLUSION: Although the quality of current evidence is very low, our findings suggest that established protocols involving mindfulness have no effect on blood glucose or glycated hemoglobin in individuals with T2DM. Indeed, large-scale trials are needed to evaluate the contribution of mindfulness to glycemic control in clinical practice. PROSPERO Registration ID: RD42020161940.
Assuntos
Diabetes Mellitus Tipo 2 , Atenção Plena , Ensaios Clínicos Controlados Aleatórios como Assunto , Autogestão , Glicemia , Diabetes Mellitus Tipo 2/terapia , Hemoglobinas Glicadas , HumanosRESUMO
BACKGROUND: Antimicrobial resistance is currently considered the main risk to global health. A variety of microbial species have been isolated from endodontic and periodontal infections. However, clinical endodontic and periodontics bacterial isolates have not been sufficiently characterized with regard to their capacity for antibiotic resistance. We aim to assess the existing evidence to estimate the prevalence of the main antimicrobial resistance and multidrug resistant organisms in endodontics and periodontics and to describe their geographic distribution in Latin America. METHODS: All types of designs and will be restricted to Latin American studies will be included in this systematic review. MEDLINE, Embase, CINAHL, BVS (LILACS, BBO - bvsalud.org), IBECS (bases.bireme.br), Google Scholar, Cochrane Central Register of Controlled Trials, and Web of Science databases will be searched from 2013 to December 31, 2018 for all types of study designs that report microbial infection in endodontics and periodontics and their resistance and that define the microbiological methods used to identify microorganisms. The selection of articles for inclusion will be performed by 2 reviewers using predefined eligibility criteria. The Cochrane and ROBINS-I risk of bias assessment tools will be used to assess the methodological quality of randomized control trials. The Newcastle-Ottawa scale will be used to assess the quality of methodology in observational studies. The overall quality of evidence will be assessed using Grading of Recommendations Assessment, Development and Evaluation (GRADE) using the same principles and domains applied in the quality assessment of prognostic studies. The heterogeneity of the findings will be assessed using both the χ test and the I statistic. Sensitivity analysis will be performed by subgroup analyses and meta-regression to investigate the effect of study-level characteristics, such as age, gender, and methodological quality score, whenever possible. Publication bias across studies will be evaluated by visual inspection of the funnel plots and Begg's test for the results covered in 10 or more studies. RESULTS: The evidence derived by this study will inform best practices for patients with endodontic and periodontal problems receiving antimicrobial agents. CONCLUSION: Successful completion will significantly impact clinical practice and contribute to improved prescribing competency. PROTOCOL REGISTRATION: PROSPERO-CRD42018077810.
Assuntos
Anti-Infecciosos/farmacologia , Anti-Infecciosos/uso terapêutico , Infecções Bacterianas/tratamento farmacológico , Resistência Microbiana a Medicamentos , Doenças Periodontais/tratamento farmacológico , Técnicas Bacteriológicas , Humanos , América Latina/epidemiologia , Periodontite Periapical/tratamento farmacológico , Projetos de PesquisaRESUMO
INTRODUCTION: The use of vasoconstrictors combined with local anaesthetics (LAs) in dentistry for patients with cardiovascular disease (CVD) is still controversial in the scientific literature. It raises concerns regarding the possibility of transient episodes, triggering negative cardiovascular outcomes. METHOD/DESIGN: Trials eligible for our systematic review will enrol patients with CVD who have undergone dental treatments carried out with the use of LAs by comparing two arms: LAs with vasoconstrictors and LAs without vasoconstrictors. The research will be conducted in the electronic databases, namely Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, Embase, Healthstar (via Ovid), Cumulative Index to Nursing and Allied Health Literature and Web of Science, from their inception to December 2017, without any restrictions in terms of language and status of publication. A team of reviewers will independently assess titles, abstracts and complete text to determine eligibility. For eligible studies, the same reviewers will perform data extraction and evaluate the risk of bias in the selected articles. The selected outcomes comprise death, mortality by a specific cause, stroke, acute myocardial infarction, hospitalisation, pain, bleeding, arrhythmias, ischaemic episodes, anxiety, adverse effects, changes in blood pressure, changes in heart rate, anxiety and results obtained via oximetry. Whenever possible, we will conduct a meta-analysis to establish the effects of LAs with and without vasoconstrictors in the patients with CVD, and the overall quality of evidence for each outcome will be determined using the Grading of Recommendations Assessment, Development and Evaluation classification system. ETHICS AND DISSEMINATION: Ethics committee approval was not necessary because this is a protocol of systematic review. This systematic review will be submitted for presentation at conferences and for publication in a peer-reviewed journal. Our review will assess the risks of cardiovascular events when using LAs with and without vasoconstrictors in patients with CVD, focusing on important clinical outcomes. PROSPERO REGISTRATION NUMBER: CRD42016045421.
Assuntos
Anestesia Local/métodos , Anestésicos Locais/administração & dosagem , Doenças Cardiovasculares , Dentística Operatória/métodos , Vasoconstritores/efeitos adversos , Doenças Cardiovasculares/mortalidade , Humanos , Revisões Sistemáticas como AssuntoRESUMO
BACKGROUND: Preliminary evidence suggests statins may reduce major perioperative vascular events. However, evidence is limited to observational studies, underpowered trials, and non-comprehensive systematic reviews. This review aims to assess the effects of perioperative statin use on cardiovascular complications in patients submitted to non-cardiac surgery. METHODS: We will search MEDLINE/PubMed, EMBASE, LILACS, CENTRAL, Web of Science, and CINAHL for randomized controlled trials assessing the effects of perioperative statin use in adults undergoing non-cardiac surgery and reporting cardiovascular complications. For patients already using statins for hyperlipidemia, a preoperative loading dose of statin is required in the experimental group. We will place no language or publication restriction on our search. Teams of two reviewers will independently assess eligibility and risk of bias, and will extract data from the included trials. Our primary outcome is a combination of cardiovascular mortality or non-fatal myocardial infarction. We will also assess the following outcomes: individual components of the primary outcome, all-cause mortality, total myocardial infarction, elevated troponin in the first seven postoperative days, total stroke, total venous thromboembolism, postoperative atrial fibrillation, elevation of creatine phosphokinase or liver enzymes, and rates of myalgia or rhabdomyolysis. We will conduct meta-analyses using random-effects model and will use trial sequential analysis to establish monitoring boundaries to limit global type I error due to repetitive testing for our primary outcome. We will rate the quality of evidence using the GRADE system. DISCUSSION: The results of this systematic review may help to inform clinical practice and also the design of future large-scale randomized trials. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42016035987.
Assuntos
Inibidores de Hidroximetilglutaril-CoA Redutases , Infarto do Miocárdio/etiologia , Assistência Perioperatória/normas , Complicações Pós-Operatórias , Procedimentos Cirúrgicos Operatórios/efeitos adversos , Humanos , Inibidores de Hidroximetilglutaril-CoA Redutases/administração & dosagem , Inibidores de Hidroximetilglutaril-CoA Redutases/efeitos adversos , Mortalidade , Ensaios Clínicos Controlados Aleatórios como Assunto , Acidente Vascular Cerebral/etiologia , Revisões Sistemáticas como AssuntoAssuntos
Humanos , Feminino , Cirurgia Geral , Lactente , Freio Lingual , Avaliação da Tecnologia Biomédica , Aleitamento MaternoRESUMO
This study addresses the methodological trends in the development of systematic reviews in public health, and examines the reviews of the Cochrane Public Health Group in order to exemplify syntheses of evidence in public health and its implementation and impact on practice and research.
Assuntos
Prática Clínica Baseada em Evidências , Saúde Pública , Organização Mundial da SaúdeRESUMO
FUNDAMENTO: O impacto do uso do ultrassom intracoronariano (USIC) na implantação de stents tem resultados inconclusivos. OBJETIVO: Revisão sistemática, com metanálise, do impacto do USIC na implantação de stents quanto à evolução clínica e angiográfica. MÉTODOS: Efetuada busca nas bases Medline/Pubmed, CENTRAL, Embase, Lilacs, Scopus e Web of Science. Incluídos estudos clínicos randomizados (ECR) que avaliaram o implante de stents, orientados pela USIC, comparados com aqueles utilizando a angiografia isoladamente (ANGIO). O intervalo mínimo de acompanhamento foi de seis meses, avaliados os desfechos: trombose, mortalidade, infarto do miocárdio, revascularização percutânea e cirúrgica, eventos cardiovasculares maiores (ECVM) e reestenose. Os desfechos binários foram apresentados considerando o número de eventos em cada grupo; as estimativas foram geradas por um modelo de efeitos aleatórios, considerando a estatística de Mantel-Haenzel como ponderadora e magnitude de efeito ao risco relativo (RR) com seu respectivo intervalo de confiança de 95% (IC 95%). Para quantificação da consistência entre os resultados de cada estudo, utilizou-se o teste de inconsistência I² de Higgins. RESULTADOS: Avaliados 2.689 artigos, incluídos 8 ECR. Houve redução de 27% na reestenose angiográfica (RR: 0,73; IC 95%: 0,54 - 0,97; I² = 51%) e redução estatisticamente significativa nas taxas de revascularizações percutânea e geral (RR: 0,88; IC 95%: 0,51 - 1,53; I² = 61% e RR: 0,73; IC 95%: 0,54 - 0,99; I² = 55%), sem diferença estatística na revascularização cirúrgica (RR: 0,95; IC 95%: 0,52 - 1,74; I² = 0%) em favor do USIC vs. ANGIO. Não foram observadas diferenças nos demais desfechos na comparação entre as duas estratégias. CONCLUSÃO: Angioplastias com implante de stents guiadas por USIC reduzem taxas de reestenose e de revascularizações, não tendo impacto nos desfechos ECVM, infarto agudo do miocárdio, mortalidade ou trombose.
BACKGROUND: The impact of intravascular ultrasound (IVUS) use on stenting has shown inconclusive results. OBJECTIVE: Systematic review and meta-analysis of the impact of IVUS on stenting regarding the clinical and angiographic evolution. METHODS: A search was performed in Medline/Pubmed, CENTRAL, Embase, Lilacs, Scopus and Web of Science databases. It included randomized clinical trials (RCTs) that evaluated the implantation of stents guided by IVUS, compared with those using angiography alone (ANGIO). The minimum follow-up duration was six months and the following outcomes were assessed: thrombosis, mortality, myocardial infarction, percutaneous and surgical revascularization, major adverse cardiovascular events (MACE) and restenosis. The binary outcomes were presented considering the number of events in each group; the estimates were generated by a random effects model, considering Mantel-Haenszel statistics as weighting agent and magnitude of effect for the relative risk (RR) with its respective 95% confidence interval (95%CI). Higgins I² test was used to quantify the consistency between the results of each study. RESULTS: A total of 2,689 articles were evaluated, including 8 RCTs. There was a 27% reduction in angiographic restenosis (RR: 0.73, 95% CI: 0.54-0.97, I² = 51%) and statistically significant reduction in the rates of percutaneous revascularization and overall (RR: 0.88; 95% CI: 0.51 to 1.53, I² = 61%, RR: 0.73, 95% CI: 0.54 to 0.99, I² = 55%), with no statistical difference in surgical revascularization (RR: 0.95, 95% CI: 0.52-1.74, I² = 0%) in favor of IVUS vs. ANGIO. There were no differences regarding the other outcomes in the comparison between the two strategies. CONCLUSION: Angioplasty with stenting guided by IVUS decreases the rates of restenosis and revascularization, with no impact on MACE, acute myocardial infarction, mortality or thrombosis outcomes.
Assuntos
Humanos , Angioplastia Coronária com Balão/métodos , Stents Farmacológicos , Ultrassonografia de Intervenção/métodos , Implantação de Prótese/métodos , Ensaios Clínicos Controlados Aleatórios como Assunto , Reprodutibilidade dos Testes , Medição de Risco , Resultado do TratamentoRESUMO
BACKGROUND: The impact of intravascular ultrasound (IVUS) use on stenting has shown inconclusive results. OBJECTIVE: Systematic review and meta-analysis of the impact of IVUS on stenting regarding the clinical and angiographic evolution. METHODS: A search was performed in Medline/Pubmed, CENTRAL, Embase, Lilacs, Scopus and Web of Science databases. It included randomized clinical trials (RCTs) that evaluated the implantation of stents guided by IVUS, compared with those using angiography alone (ANGIO). The minimum follow-up duration was six months and the following outcomes were assessed: thrombosis, mortality, myocardial infarction, percutaneous and surgical revascularization, major adverse cardiovascular events (MACE) and restenosis. The binary outcomes were presented considering the number of events in each group; the estimates were generated by a random effects model, considering Mantel-Haenszel statistics as weighting agent and magnitude of effect for the relative risk (RR) with its respective 95% confidence interval (95%CI). Higgins I² test was used to quantify the consistency between the results of each study. RESULTS: A total of 2,689 articles were evaluated, including 8 RCTs. There was a 27% reduction in angiographic restenosis (RR: 0.73, 95% CI: 0.54-0.97, I² = 51%) and statistically significant reduction in the rates of percutaneous revascularization and overall (RR: 0.88; 95% CI: 0.51 to 1.53, I² = 61%, RR: 0.73, 95% CI: 0.54 to 0.99, I² = 55%), with no statistical difference in surgical revascularization (RR: 0.95, 95% CI: 0.52-1.74, I² = 0%) in favor of IVUS vs. ANGIO. There were no differences regarding the other outcomes in the comparison between the two strategies. CONCLUSION: Angioplasty with stenting guided by IVUS decreases the rates of restenosis and revascularization, with no impact on MACE, acute myocardial infarction, mortality or thrombosis outcomes.
